protein

Recombinant Canine TNF RI/TNFRSF1A Protein, CF

4017-TR-025/CF

25 ug

456 USD

4017-TR-025/CF

Recombinant Canine TNF RI/TNFRSF1A Protein, CF

25 ug

The Recombinant Canine TNF RI/TNFRSF1A Protein, CF from R&D Systems is derived from E. coli. The Recombinant Canine TNF RI/TNFRSF1A Protein, CF has been validated for the following applications: Bioactivity.

TNF RI/TNFRSF1A

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain

Canine

21.6 kDa

Measured by its ability to inhibit the TNF-alpha mediated cytotoxicity in the L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews,áN. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al . (eds): IRL Press. 221. The ED50 for this effect is 0.04-0.2 ╡g/mL in the presence of 15 ng/mL of rcaTNF-alpha .

<0.01 EU per 1 ╡g of the protein by the LAL method.

XP_854474

Bioactivity

E. coli -derived canine TNF RI/TNFRSF1A protein Ile22-Thr211, with an N-terminal Met

E. coli

456 USD

CD120a, CD120a antigen, FPF, p55, p55-R, p60, TNFARMGC19588, TNF-R, TNF-R1, TNFR1TBP1, TNFR55, TNF-R55, TNFR60, TNFRI, TNF-RI, TNF-R-I, TNFR-I, TNFRSF1A, tumor necrosis factor binding protein 1, Tumor necrosis factor receptor 1, tumor necrosis factor receptor 1A isoform beta, tumor necrosis factor receptor superfamily member 1A, tumor necrosis factor receptor superfamily, member 1A, tumor necrosis factor receptor type 1, Tumor necrosis factor receptor type I, tumor necrosis factor-alpha receptor

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.